Studies have shown that EGCG, the main component of catechin, inhibits programmed cell death ligand 1 (PD-L1) in lung cancer cells induced by interferon (INF-γ) and EGF, even JAK2/STAT1 expression (110). The gene discussed is CD274; the disease is lung cancer.